Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome

Human Genetics

Volumn 133, Issue 9, 2014, Pages 1075-1082

  Massingham, Lauren J ^a   Johnson, Kirby L ^b   Scholl, Thomas M ^c   Slonim, Donna K ^b,d   Wick, Heather C ^d   Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LABORATORY CORPORATION OF AMERICA   (United States)

^d Tufts University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE RNA; ELF4 PROTEIN; FRMPD4 PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; NFATC3 PROTEIN; NKRF PROTEIN; NOVA2 PROTEIN; PROTEIN; RBM3 PROTEIN; RNA; SHORT STATURE HOMEOBOX PROTEIN; SLC48A1 PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; TRANSCRIPTOME; UNCLASSIFIED DRUG; X INACTIVE SPECIFIC TRANSCRIPT PROTEIN; ZNF2 PROTEIN;

AMNION FLUID; ANEUPLOIDY; ARTICLE; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENOME; GESTATIONAL AGE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LIPID METABOLISM; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SIGNAL TRANSDUCTION; TRISOMY 18; TRISOMY 21; TURNER SYNDROME; UPREGULATION;

AMNIOTIC FLUID; ANEUPLOIDY; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, X; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; KARYOTYPE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PHENOTYPE; PILOT PROJECTS; PREGNANCY; RNA, MESSENGER; TRANSCRIPTOME; TURNER SYNDROME; UP-REGULATION;

EID: 84907424801     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1448-y     Document Type: Article

References (36)

1. Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K, Arepalli S, Vanderhoof V, Nelson LM, Bondy CA (2012) Autoimmune disorders in women with Turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 38:315–321
2. Bianchi D, Crombleholme T, D’Alton M, Malone F (2010) 45,X (Turner syndrome). In: Fetology: Diagnosis and management of the fetal patient, 2nd edn. McGraw-Hill Companies, New York
3. Bierer R, Nitta CH, Friedman J, Codianni S, de Frutos S, Dominguez-Bautista JA, Howard TA, Resta TC, Gonzalez Bosc LV (2011) NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice. Am J Physiol Lung Cell Mol Physiol 301:L872–L880
4. Bondy CA (2007) Turner syndrome study group: care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab 92:10–25
5. Clarkson PM, Nicholson MR, Barratt-Boyes BG, Neutze JM, Whitlock RM (1983) Results after repair of coarctation of the aorta beyond infancy: a 10–28 years follow-up with particular reference to late systemic hypertension. Am J Cardiol 51:1481–1488
6. de Frutos S, Caldwell E, Nitta CH, Kanagy NL, Wang J, Wang W, Walker MK, Gonzalez Bosc LV (2010) NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice. Am J Physiol Heart Circ Physiol 299:H356–H363
7. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E (2002) Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143:3955–3962
8. Dietz JA, Johnson KL, Massingham LJ, Schaper J, Horlitz M, Cowan J, Bianchi DW (2011) Comparison of extraction techniques for amniotic fluid supernatant demonstrates improved yield of cell-free fetal RNA. Prenat Diagn 31:598–599
9. Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner’s syndrome in adulthood. Endocr Rev 23:120–140
10. FitzSimmons J, Fantel A, Shepard TH (1994) Growth parameters in mid-trimester fetal Turner syndrome. Early Hum Dev 38:121–129
11. Giordano R, Forno D, Lanfranco F, Manieri C, Ghizzoni L, Ghigo E (2011) Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. Eur J Endocrinol 164:819–826
12. Gobert M, Lafaille JJ (2012) Maternal–fetal immune tolerance, block by block. Cell 150:7–9
13. Gravholt CH (2004) Epidemiological, endocrine, and metabolic features in Turner syndrome. Eur J Endocrinol 151:657–687
14. Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51:147–158
15. Hall JG, Sybert VP, Williamson RA, Risher NL, Reed SD (1982) Turner’s syndrome. West J Med 137:32–44
16. Hintz RL (2002) SHOX mutations. Rev Endocr Metab Disord 3:363–367
17. Horsley V, Pavlath GK (2002) NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156:771–774
18. Hui L, Slonim DK, Wick HC, Johnson KL, Bianchi DW (2012a) The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol 119:111–118
19. Hui L, Slonin DK, Wick HC, Johnson KL, Koide K, Bianchi DW (2012b) Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21. Hum Genet 131:1751–1759
20. Jørgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M (2010) Autoimmune diseases in women with Turner’s syndrome. Arthr Rheum 62:658–666
21. Kanatani M, Sugimoto T, Nishiyama K, Chihara K (2000) Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity. J Bone Miner Res 15:902–910
22. Kenny D, Polson JW, Martin RP, Paton JF, Wolf AR (2011) Hypertension and coarctation of the aorta: an inevitable consequence of developmental pathophysiology. Hypertens Res 34:543–547
23. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR (2007) Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18:4543–4552
24. Koide K, Slonim DK, Johnson KL, Tantravahi U, Cowan JM, Bianchi DW (2011) Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet 129:295–305
25. Kojima H, Kunimoto H, Inoue T, Nakajima K (2012) The STAT3–IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts. Cell Cycle 11:730–739
26. Larrabee PB, Johnson KL, Lai C, Ordovas J, Cowan JM, Tantravahi U, Bianchi DW (2005) Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA 293:836–842
27. Nielsen J, Wohlert M (1991) Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87:81–83
28. Papp C, Beke A, Mezi G, Szigeti Z, Ban Z, Papp Z (2006) Prenatal diagnosis of Turner syndrome; report on 69 cases. J Ultrasound Med 25:711–717
29. Pavlidis P, Li Q, Noble WS (2003) The effect of replication on gene expression microarray experiments. Bioinformatics 19(13):1620–1627
30. Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB Jr (1995) Lipid abnormalities in Turner syndrome. J Pediatr 126:242–245
31. Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM (2004) Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA 101:4314–4319
32. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW (2009) Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA 106:9425–9429
33. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062–6067
34. Tyler C, Edman JC (2004) Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span. Prim Care 31:627–648
35. Van PL, Bakalov VD, Bondy CA (2006) Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J Clin Endocrinol Metab 91:2867–2870
36. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW 3rd, Su AI (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10:R130